2010
DOI: 10.1002/ajmg.a.33453
|View full text |Cite
|
Sign up to set email alerts
|

CDKN1C (p57Kip2) analysis in Beckwith–Wiedemann syndrome (BWS) patients: Genotype–phenotype correlations, novel mutations, and polymorphisms

Abstract: Beckwith-Wiedemann syndrome (BWS) is an overgrowth syndrome characterized by macroglossia, macrosomia, and abdominal wall defects. It is a multigenic disorder caused in most patients by alterations in growth regulatory genes. A small number of individuals with BWS (5-10%) have mutations in CDKN1C, a cyclin-dependent kinase inhibitor of G1 cyclin complexes that functions as a negative regulator of cellular growth and proliferation. Here, we report on eight patients with BWS and CDKN1C mutations and review previ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
83
0
2

Year Published

2011
2011
2016
2016

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 67 publications
(92 citation statements)
references
References 44 publications
7
83
0
2
Order By: Relevance
“…18 The presence of genome-wide UPD was tested in 28 UPD patients by microsatellite analysis and single-nucleotide polymorphism array. CDKN1C gene sequencing as described elsewhere 19 was carried out in 154 patients selected on the basis of negativity of methylation sensitive tests plus 2 of the above-mentioned BWS diagnostic criteria and either familiarity for BWS or signs/malformations highly specific for CDKN1C variants (as palatoschisis or omphalocele). 3 Pathogenicity prediction of CDKN1C variants was tested by the bioinformatic tools PolyPhen-2 (Polymorphism Phenotyping), SIFT (Sorting Intolerant From Tolerant), and PROVEAN (Protein Variation Effect Analyzer).…”
Section: Genotypingmentioning
confidence: 99%
“…18 The presence of genome-wide UPD was tested in 28 UPD patients by microsatellite analysis and single-nucleotide polymorphism array. CDKN1C gene sequencing as described elsewhere 19 was carried out in 154 patients selected on the basis of negativity of methylation sensitive tests plus 2 of the above-mentioned BWS diagnostic criteria and either familiarity for BWS or signs/malformations highly specific for CDKN1C variants (as palatoschisis or omphalocele). 3 Pathogenicity prediction of CDKN1C variants was tested by the bioinformatic tools PolyPhen-2 (Polymorphism Phenotyping), SIFT (Sorting Intolerant From Tolerant), and PROVEAN (Protein Variation Effect Analyzer).…”
Section: Genotypingmentioning
confidence: 99%
“…During pregnancy, preeclampsia or eclampsia may occur. 35,36 Silver-Russell syndrome SRS is characterized by intrauterine and postnatal growth restriction with a typical facial gestalt (for a review, Saal 16 ). In the majority of patients, birth weight is 2-3 s.d.…”
Section: Clinical Findings In Bws and Srsmentioning
confidence: 99%
“…Maternally-inherited loss of function mutations in CDKN1C are reported in about 10% of BWS patients and about 40% of familial cases of BWS . BWS patients with CDKN1C mutations are more likely to have polydactyly, genital abnormalities, cleft palate and are less likely to develop tumors compared with other molecular causes of BWS, suggesting that decreased CDKN1C expression disrupts development of these organ systems (Kantaputra et al, 2013, Romanelli et al, 2010. Activating mutations in CDKN1C have been reported in RSS patients (Azzi et al, 2014).…”
Section: Beckwith-wiedemann Syndrome and Russell-silver Syndromementioning
confidence: 99%